Paul Choi
Stock Analyst at Goldman Sachs
Total Price Targets
10
Stocks Covered
8
Sectors
Healthcare
Most Recent
Oct 30, 2025
Notable Calls (Last 12 Months)
Stocks Covered by Paul Choi
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | $100.00 | $66.88 | +49.5% | 2 | Oct 30, 2025 |
| URGN | UroGen Pharma Ltd. | $16.00 | $31.58 | -49.3% | 2 | Jun 13, 2025 |
| LNTH | Lantheus Holdings, Inc. | $143.00 | $105.20 | +35.9% | 1 | Dec 18, 2024 |
| CYTK | Cytokinetics, Incorporated | $60.00 | $76.32 | -21.4% | 1 | Sep 3, 2024 |
| PHAT | Phathom Pharmaceuticals, Inc. | $12.00 | $10.50 | +14.3% | 1 | Aug 8, 2024 |
| RGNX | REGENXBIO Inc. | $38.00 | $6.97 | +445.2% | 1 | Jun 7, 2024 |
| PTCT | PTC Therapeutics, Inc. | $32.00 | $74.03 | -56.8% | 1 | May 20, 2024 |
| VIR | Vir Biotechnology, Inc. | $28.38 | $8.65 | +228.1% | 1 | Feb 21, 2023 |
Recent Activity
- Oct 30, 2025— Set$100.00price target onBBIO(BridgeBio Pharma, Inc.)
- Jun 13, 2025— Set$16.00price target onURGN(UroGen Pharma Ltd.)
- Dec 18, 2024— Set$143.00price target onLNTH(Lantheus Holdings, Inc.)
- Sep 3, 2024— Set$60.00price target onCYTK(Cytokinetics, Incorporated)
- Aug 8, 2024— Set$12.00price target onPHAT(Phathom Pharmaceuticals, Inc.)
- Jun 14, 2024— Set$22.00price target onURGN(UroGen Pharma Ltd.)
- Jun 7, 2024— Set$38.00price target onRGNX(REGENXBIO Inc.)
- May 30, 2024— Set$50.00price target onBBIO(BridgeBio Pharma, Inc.)
- May 20, 2024— Set$32.00price target onPTCT(PTC Therapeutics, Inc.)
- Feb 21, 2023— Set$28.38price target onVIR(Vir Biotechnology, Inc.)
Frequently Asked Questions
Who is Paul Choi?
Paul Choi is a stock analyst at Goldman Sachs covering 8 stocks primarily in Healthcare. They have issued 10 price targets since Feb 21, 2023.
What stocks does Paul Choi cover?
Paul Choi currently covers 8 stocks, including BBIO, URGN, LNTH, CYTK, PHAT.
What is Paul Choi's latest price target?
Paul Choi's most recent price target was $100.00 on BBIO (BridgeBio Pharma, Inc.), set on Oct 30, 2025.
What is Paul Choi's highest price target?
Paul Choi's highest issued price target is $143.00 on LNTH, set on Dec 18, 2024.
More Analysts at Goldman Sachs
Coverage based on publicly published price targets. Not investment advice.